Skip to search formSkip to main contentSkip to account menu

Cardioplegin

Known as: Magnesate(2-), bis(L-aspartato(2-)-N,O1)-, (T-4)-, dihydrogen, mixt. with 2-(diethylamino)ethyl 4-aminobenzoate monohydrochloride 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Aspartic AcidProcaineSorbitol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
특집 : 1991 년도 추계 연수강좌 ; 호흡기질환 환자의 마취관리
Background: Verapamil, a calcium channel blocker, is known to protect the myocardium against ischemia and reperfusion injury. The… 
1981
1981
[Initial results of using Cardioplegin in heart operations].
1979
1979
Myocardial protection during heart surgery. An experimental evaluation of normothermic and hypothermic cardioplegia.
Heart surgery with hypothermic cardioplegia during normothermic bypass is sometimes complicated by rewarming of the myocardium… 
1979
1979
[Myocardial metabolic status in various methods of inducing a reversible heart arrest].
In experiments with dogs, three different methods of inducing a reversible cardiac arrest were compared: (A) the ischemic arrest… 
1978
1978
[Animal experiment evaluation of myocardial protection with a magnesium-asparaginate-procaine solution].
Cardioplegic myocardial protection with magnesium asparaginate procaine (Cardioplegin) is assessed in normothermic ischemia by… 
1973
1973
[Usefulness of Cardioplegin in surgery with extracorporeal circulation].